Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Australian Government IP Australia
Additional fields:

Trade mark 2607743

Words AMPOVIOS
Image
Image description
Status registered: Registered/protected
Priority date 24 Jun 2025 (Convention)
Class 5
Kind Word
Dates
Renewal due 27 Nov 2035
Registration advertised / published 11 Feb 2026
Entered on Register 11 Feb 2026
Acceptance advertised / published 04 Dec 2025
Acceptance 04 Dec 2025
Filing 27 Nov 2025
Registered from 27 Nov 2025

Owner Address for service
Vertex Pharmaceuticals Incorporated
PHILLIPS ORMONDE FITZPATRICK

Goods & Services
Class 5: pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders

Convention details
Date 24 Jun 2025
Number 99/250,876
Country UNITED STATES OF AMERICA
Goods & Services
Class 5:
pharmaceutical preparations for the treatment of immune system related diseases and disorders;pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia;pharmaceutical preparations for the treatment of kidney diseases and disorders;pharmaceutical preparations for the treatment of blood diseases and disorders;pharmaceutical preparations for the treatment of inflammation related diseases and disorders;pharmaceutical preparations for the treatment of autoimmune diseases and disorders;pharmaceutical preparations for the treatment of immunoglobulin A nephropathy;pharmaceutical preparations for the treatment of primary membranous nephropathy;pharmaceutical preparations for the treatment of lupus nephritis;pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis;pharmaceutical preparations for the treatment of immune thrombocytopenia;pharmaceutical preparations for the treatment of immune thrombocytopenia purpura;pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia

Indexing constituents
Word Image